Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$40.29 - $82.51 $734,849 - $1.5 Million
-18,239 Reduced 18.09%
82,588 $3.43 Million
Q1 2023

May 15, 2023

BUY
$56.44 - $118.81 $845,414 - $1.78 Million
14,979 Added 17.45%
100,827 $6.06 Million
Q4 2022

Feb 14, 2023

SELL
$63.98 - $85.37 $67,498 - $90,065
-1,055 Reduced 1.21%
85,848 $6.3 Million
Q3 2022

Nov 14, 2022

SELL
$67.99 - $89.57 $362,318 - $477,318
-5,329 Reduced 5.78%
86,903 $6.6 Million
Q2 2022

Aug 15, 2022

SELL
$56.6 - $89.9 $830,322 - $1.32 Million
-14,670 Reduced 13.72%
92,232 $6.41 Million
Q1 2022

May 16, 2022

BUY
$60.15 - $84.52 $502,974 - $706,756
8,362 Added 8.49%
106,902 $8.86 Million
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $947,809 - $1.54 Million
12,624 Added 14.69%
98,540 $7.4 Million
Q3 2021

Nov 15, 2021

BUY
$116.17 - $194.55 $443,188 - $742,208
3,815 Added 4.65%
85,916 $9.98 Million
Q2 2021

Aug 16, 2021

BUY
$130.4 - $225.58 $2.64 Million - $4.57 Million
20,272 Added 32.79%
82,101 $18.2 Million
Q1 2021

May 14, 2021

BUY
$124.11 - $190.17 $274,407 - $420,465
2,211 Added 3.71%
61,829 $8.17 Million
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $92,419 - $143,491
824 Added 1.4%
59,618 $10.3 Million
Q3 2020

Nov 13, 2020

BUY
$58.05 - $111.31 $1.89 Million - $3.63 Million
32,572 Added 124.22%
58,794 $6.54 Million
Q1 2020

May 15, 2020

BUY
$57.05 - $95.75 $1.5 Million - $2.51 Million
26,222 New
26,222 $1.77 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.79B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Capital International LTD Portfolio

Follow Capital International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.